[1] 程熠,史方亮,王之光,等.溶栓素的纯化研究[J].白求恩医科大学学报,2001,27(1):9-11.
[2] 程熠,洪敏,李奇,等.阴、阳离子交换示差组合色谱法的设计及在纤溶酶纯化中的应用[J]. 吉林大学学报:医学版,2005,31(5):699-701.
[3] 程熠,洪敏,张云龙. 溶栓素产品纯度的检测[J]. 吉林大学学报:医学版,2004,30(5):816-818.
[4] 程熠,洪敏,张云龙. 溶栓素定量方法的筛选系统[J]. 吉林大学学报:医学版,2004,30(6):981-983.
[5] 李奇,洪敏,付海英. 溶栓素抗凝血和抗血栓形成作用的实验研究[J]. 吉林大学学报:医学版,2004,30(3):401-404.
[6] 李奇,迟秀梅,石立红,等. N-V蛋白酶体内外纤维蛋白溶解活性的实验研究[J]. 中国药理学通报,2006,22(8):976-979.
[7] Peters BH, Staels L, Rantanen J, et al. Effects of cooling rate in microscale and pilot scale freeze-drying-variations in excipient polymorphs and protein secondary structure[J]. Eur J Pharm Sci,2016, 95:72-81.
[8] Ulrichs T, Drotleff AM, Ternes W. Determination of heat-induced changes in the protein secondary structure of reconstituted livetins (water-soluble proteins from hen's egg yolk) by FTIR[J]. Food Chem, 2015, 172:909-920.
[9] Park J, Nagapudi K, Vergara C, et al. Effect of pH and excipients on structure, dynamics, and long-term stability of a model IgG1 monoclonal antibody upon freeze-drying[J]. Pharm Res,2013, 30(4):968-984.
[10] Depaz RA, Pansare S, Patel SM. Freeze-drying above the glass transition temperature in amorphous protein formulations while maintaining product quality and improving process efficiency[J]. J Pharm Sci, 2016, 105(1):40-49.
[11] Chang BS, Kendrick BS, Carpenter JF. Surface-induced denaturation of proteins during freezing and its inhibition by surfactants[J]. J Pharm Sci, 1996, 85(12):1325-1330.
[12] Sarciaux JM, Hageman MJ. Effects of bovine somatotropin (rbSt) concentration at different moisture levels on the physical stability of sucrose in freeze-dried rbSt/sucrose mixtures[J]. J Pharm Sci, 1997, 86(3):365-371.
[13] Strambini GB, Gabellieri E. Proteins in frozen solutions:evidence of ice-induced partial unfolding[J]. Biophys J, 1996, 70(2):971-976.
[14] Jiang S, Nail SL. Effect of process conditions on recovery of protein activity after freezing and freeze-drying[J]. Eur J Pharm Biopharm, 1998, 45(3):249-257.
[15] Cleland JL, Powell MF, Shire SJ. The development of stable protein formulations:a close look at protein aggregation, deamidation, and oxidation[J]. Crit Rev Ther Drug Carrier Syst, 1993, 10(4):307-377.
[16] Knepp VM, Whatley JL, Muchnik A, et al. Identification of antioxidants for prevention of peroxide-mediated oxidation of recombinant human ciliary neurotrophic factor and recombinant human nerve growth factor[J]. PDA J Pharm Sci Technol, 1996, 50(3):163-171. |